Live
FierceBiotechEntrada's stock craters as DMD data underperform expectations, handing advantage to NovartisFierceBiotechRoche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnosticsPromega BlogWhat Counts as EvidenceFierceBiotechFrom drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’Lonza NewsBMS Licenses SYNtecan Linker-Payload Platform from Lonza - Contract PharmaIlluminaAi In Genomics Market Is Going to Boom | Illumina, IBM, Google - openPR.comEndpoints NewsAtara, Pierre Fabre's cell therapy to get another shot at FDA approvalFierceBiotechInsulet boosts guidance in Q1 update as it grapples with recall sagaPharmaVoiceLilly, Gilead lead pharma’s M&A boomLabiotechThe rise of trispecific antibodies: Biopharma’s next big bet after bispecificsEndpoints NewsPennsylvania sues AI chatbot company for posing as a licensed doctorNovo NordiskNovo Nordisk faces competition from Canada compounders - medwatch.com

Archiv

Aktuell Älteste Löschen
Gesamt 403
Seite 12 / 23
Suche --